MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$105K
Net Income
-$3,164K
Net Profit Margin
-3013.33%
EPS
-$0.23
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Government contract revenue
105
225
-
-
Research and development
2,142
1,371
1,941*
954
General and administrative
1,147
1,210
783*
1,135
Total operating expenses
3,289
2,581
2,723
2,089
Loss from operations
-3,184
-2,356
-2,723*
-2,089
Interest income, net
-10
-22
-59*
-22
Foreign exchange loss (gain)
10
35
-10*
18
Total other income, net
20
57
49*
40
Net loss
-3,164
-2,299
-2,675
-2,049
Basic EPS
-0.23
-0.17
-0.211
-0.19
Diluted EPS
-0.23
-0.17
-0.211
-0.19
Basic Average Shares
13,788,000
13,786,000
12,705,000
10,991,000
Diluted Average Shares
13,788,000
13,786,000
12,705,000
10,991,000
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Foreign exchange loss
(gain)
$10K
(-60.00%↓ Y/Y)
Interest income, net
-$10K
(64.29%↑ Y/Y)
Net loss
-$3,164K
(-53.97%↓ Y/Y)
Total other income,
net
$20K
(-62.26%↓ Y/Y)
Loss from operations
-$3,184K
(-51.04%↓ Y/Y)
Government contract
revenue
$105K
Total operating
expenses
$3,289K
(56.02%↑ Y/Y)
Research and development
$2,142K
(90.91%↑ Y/Y)
General and
administrative
$1,147K
(16.33%↑ Y/Y)
Buy us a coffee
Cocrystal Pharma, Inc. (COCP)
Cocrystal Pharma, Inc. (COCP)